Market Tracker

09/22 5:16pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

432.72
Delayed Data
As of Sep 22
 -0.73 / -0.17%
Today’s Change
325.35
Today|||52-Week Range
543.55
+17.88%
Year-to-Date

Today’s Trading

Previous close433.45
Today’s open431.12
Day’s range427.04 - 433.77
Volume626,312
Average volume (3 months)849,493
Market cap$46.4B
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+31.36%
Earnings growth (next 5 years)+13.86%
Revenue growth (last year)+18.44%
P/E ratio43.4
Price/Sales8.79
Price/Book10.31

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.27-0.17%
VRTXVertex Pharmaceutica...-0.80-0.53%
BAXBaxter International...+0.13+0.21%
ALXNAlexion Pharmaceutic...-0.10-0.07%
Data as of 4:04pm ET, 09/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$3.83
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts